Acadian Asset Management
HRTX icon

Acadian Asset Management’s Heron Therapeutics HRTX Stock Holding History

Acadian Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$409K Buy
+513,168
New +$595K ﹤0.01% 1413
2024
Q4 		– Sell
-7,601
Closed -$15K – 1864
2024
Q3 		$15K Sell
7,601
-28,861
-79% -$68.9K ﹤0.01% 2010
2024
Q2 		$127K Buy
+36,462
New +$112K ﹤0.01% 1502
2024
Q1 		– Sell
-134,877
Closed -$229K – 1659
2023
Q4 		$229K Buy
+134,877
New +$149K ﹤0.01% 1215
2018
Q4 		– Sell
-183
Closed -$6K – 1764
2018
Q3 		$6K Buy
+183
New +$6.82K ﹤0.01% 1612

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Acadian Asset Management's HRTX Position: Q1 2026 in Review

Acadian Asset Management opened a new position in Heron Therapeutics (HRTX) in Q1 2026: 513,168 shares worth $409K. The stake represents ﹤0.01% of the portfolio and ranks #1413 among its holdings. This is a return to the name: Acadian Asset Management previously reported a position in HRTX as recently as Q3 2024.

Acadian Asset Management first reported a position in HRTX in Q3 2018 and has held it in 5 quarters since. 167 funds tracked by Wall St. Rank hold HRTX as of Q1 2026.

  • Acadian Asset Management held 513,168 shares of Heron Therapeutics worth $409K as of Q1 2026.
  • Heron Therapeutics was a new Acadian Asset Management position in Q1 2026.
  • Heron Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q1 2026, its #1413 holding.
  • Acadian Asset Management first reported a position in Heron Therapeutics in Q3 2018 and has held it in 5 quarters since.
  • 167 funds tracked by Wall St. Rank held Heron Therapeutics as of Q1 2026.

Based on Acadian Asset Management's 13F filing for Q1 2026, filed 13 May 2026.